
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.2 | 12.7118644068 | 9.44 | 11.52 | 8.53 | 494518 | 9.95606224 | CS |
4 | -1.56 | -12.7868852459 | 12.2 | 13.425 | 8.53 | 293468 | 10.8555693 | CS |
12 | -1.88 | -15.0159744409 | 12.52 | 13.91 | 8.53 | 294518 | 11.75110749 | CS |
26 | -4.61 | -30.2295081967 | 15.25 | 16.5431 | 8.53 | 274992 | 13.16459557 | CS |
52 | -7.93 | -42.7032848681 | 18.57 | 22.188 | 8.53 | 296009 | 15.29013342 | CS |
156 | 0.8 | 8.13008130081 | 9.84 | 22.188 | 4.81 | 151062 | 13.85547203 | CS |
260 | 3.73 | 53.979739508 | 6.91 | 33.01 | 4.03 | 123467 | 15.7781389 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.